Rejuvel Bio-Sciences, Inc. (NUUU)

Rejuvel Bio-Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010
Period Ending	Sep 30, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
Revenue	0.19	0.09	0.05	0.01	0	-
Revenue Growth (YoY)	135.94%	82.50%	546.18%	431.93%	-	-
Cost of Revenue	0.1	0.08	0.03	0	0	-
Gross Profit	0.09	0.01	0.02	0	0	-
Selling, General & Admin	1.35	0.7	0.55	0.68	0.23	0.02
Operating Expenses	1.35	0.7	0.55	0.68	0.23	0.02
Operating Income	-1.26	-0.69	-0.53	-0.68	-0.23	-0.02
Interest Expense	-0.24	-0.1	-0.25	-0.23	-	-
Other Non Operating Income (Expenses)	0.45	0.43	0.06	0.08	-	-
EBT Excluding Unusual Items	-1.05	-0.35	-0.72	-0.83	-0.23	-0.02
Other Unusual Items	-	-	0	-	-	-
Pretax Income	-1.05	-0.35	-0.72	-0.83	-0.23	-0.02
Net Income	-1.05	-0.35	-0.72	-0.83	-0.23	-0.02
Net Income to Common	-1.05	-0.35	-0.72	-0.83	-0.23	-0.02
Shares Outstanding (Basic)	50	95	117	117	25	3
Shares Outstanding (Diluted)	50	95	117	117	25	3
Shares Change (YoY)	-55.32%	-19.40%	0.03%	362.93%	734.27%	1.17%
EPS (Basic)	-0.02	-0.00	-0.01	-0.01	-0.01	-0.01
EPS (Diluted)	-0.02	-0.00	-0.01	-0.01	-0.01	-0.01
Free Cash Flow	-0.62	-0.51	-0.31	-0.68	-0.23	-0.02
Free Cash Flow Per Share	-0.01	-0.01	-0.00	-0.01	-0.01	-0.01
Gross Margin	47.41%	11.47%	48.01%	51.51%	58.33%	-
Operating Margin	-672.70%	-730.32%	-1027.38%	-8494.36%	-15189.20%	-
Profit Margin	-561.59%	-375.01%	-1387.82%	-10453.43%	-15189.20%	-
Free Cash Flow Margin	-332.85%	-544.25%	-597.30%	-8509.61%	-15556.67%	-
EBITDA	-1.25	-0.68	-0.53	-0.67	-0.22	-0.02
D&A For EBITDA	0.01	0.01	0	0	0	0
EBIT	-1.26	-0.69	-0.53	-0.68	-0.23	-0.02

Source: S&P Capital IQ. Standard template. Financial Sources.